AAAAAA
Results:
1-14
|
Results: 14
Authors:
MORERE JF
PIPERNONEUMANN S
BRUNET A
BOAZIZ C
KOHN M
BOUILLET T
BREAU JL
Citation: Jf. Morere et al., VINORELBINE AND IFOSFAMIDE FOR UNRESECTABLE NONSMALL CELL LUNG-CANCER, Lung cancer, 18(1), 1997, pp. 95-100
Authors:
TOURANI JM
JAILLONABRAHAM C
LUCAS V
CHRETIEN Y
MAYEUR D
DIPALMA M
BOAZIZ C
GRISE P
VARETTE C
PAVLOVITCH JM
LARREGAIN D
ECSTEIN E
UNTEREINER M
ANDRIEU JM
Citation: Jm. Tourani et al., SUBCUTANEOUS ADMINISTRATION OF INTERLEUKIN-2 IN TREATMENT OF PATIENTSWITH METASTATIC RENAL-CELL CARCINOMA - 3-YEAR RESULTS OF SCAPP-I TRIAL, Bulletin du cancer, 84(4), 1997, pp. 351-356
Authors:
TOURANI JM
GRISE P
LUCAS V
MAYEUR D
DUFOUR B
DIPALMA M
BOAZIZ C
PAVLOVITCH JM
PUJADELAURAINE E
LARREGAIN D
UNTEREINER M
Citation: Jm. Tourani et al., INTERLEUKIN-2 IN OUTPATIENTS WITH RENAL-CELL CARCINOMA - SCAPP1 TRIAL, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(5), 1996, pp. 297-300
Authors:
BERENGER N
MORETTI JL
BOAZIZ C
VIGNERON N
MORERE JF
BREAU JL
Citation: N. Berenger et al., SOMATOSTATIN RECEPTOR IMAGING IN SMALL-CELL LUNG-CANCER, European journal of cancer, 32A(8), 1996, pp. 1429-1431
Authors:
TOURANI JM
LUCAS V
MAYEUR D
DUFOUR B
DIPALMA M
BOAZIZ C
GRISE P
VARETTE C
PAVLOVITCH JM
PUJADELAURAINE E
LARREGAIN D
ECSTEIN E
UNTEREINER M
VUILLEMIN E
MERRAN S
ANDRIEU JM
Citation: Jm. Tourani et al., SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 (RIL-2) IN OUT-PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA - RESULTS OF A MULTICENTER SCAPP1 TRIAL, Annals of oncology, 7(5), 1996, pp. 525-528
Authors:
KHAYAT D
BANZET P
WEIL M
FUMOLEAU P
AVRIL MF
NAMER M
BONNETERRE J
KERBRAT P
BONERANDI JJ
BUGAT R
MONTCUQUET P
CUPISSOL D
LAUVIN R
VILMER C
BOAZIZ C
COUR V
BIZZARI JP
Citation: D. Khayat et al., FOLLOW-UP OF 153 MELANOMA EVALUABLE PATIENTS TREATED BY FOTEMUSTINE -PROGNOSIS FACTORS FOR RESPONSE AND SURVIVAL, Medicamentos de actualidad, 32, 1996, pp. 35-41
Authors:
RAYMOND E
HAON C
BOAZIZ C
COSTE M
Citation: E. Raymond et al., LOGISTIC-REGRESSION MODEL OF FOTEMUSTINE TOXICITY COMBINING INDEPENDENT PHASE-II STUDIES, Cancer, 78(9), 1996, pp. 1980-1987
Authors:
BREAU JL
BOUILLET Z
MAZERON JJ
MORERE JF
PIPERNONEUMAN S
BOAZIZ C
HADDAD E
Citation: Jl. Breau et al., INDUCTION CHEMOTHERAPY (INDCT) AND CONCURRENT BI WEEKLY INFUSION OF 5-FU AND CISPLATIN (CDDP) COMBINED WITH CONCOMITANT CHEST IRRADIATION (CCRT) IN LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 31A, 1995, pp. 1089-1089
Authors:
MORETTI JL
CAGLAR M
BOAZIZ C
CAILLATVIGNERON N
MORERE JF
Citation: Jl. Moretti et al., SEQUENTIAL FUNCTIONAL IMAGING WITH TC-99M HEXAKIS-2-METHOXYISOBUTYLISONITRILE AND IN-111 OCTREOTIDE - CAN WE PREDICT THE RESPONSE TO CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER, European journal of nuclear medicine, 22(2), 1995, pp. 177-180
Authors:
MORERE JF
DURAN A
TCHERAKIAN F
BOAZIZ C
VALEYRE D
BATTESTI JP
BREAU JL
ISRAEL L
Citation: Jf. Morere et al., CISPLATIN 5-FLUOROURACIL IN SMALL-CELL LUNG-CANCER - A PHASE-II STUDYIN 109 PATIENTS, Lung cancer, 11(3-4), 1994, pp. 275-281
Authors:
ISRAEL L
BREAU JL
MORERE JF
BOAZIZ C
Citation: L. Israel et al., EVALUATION OF THE ANTIPROSTAGLANDIN AGENT PIROXICAM IN 87 PATIENTS WITH ADVANCED CANCER, La Semaine des hopitaux de Paris, 69(35), 1993, pp. 1293-1297
Authors:
BOAZIZ C
MAZERON JJ
MORERE JF
BREAU JL
ISRAEL L
Citation: C. Boaziz et al., UVEAL MELANOMA, Bulletin du cancer, 80(7), 1993, pp. 577-583
Authors:
RAYMOND E
BOAZIZ C
KOMAROVER H
BREAU JL
MOLIARD M
MORERE JF
ISRAEL L
Citation: E. Raymond et al., RENAL-CELL CARCINOMA - VARIATIONS OF BLOOD LYMPHOCYTE SUBPOPULATIONS UNDER TREATMENT BY INTERFERON-ALPHA-2B AND R-INTERLEUKIN-2, Bulletin du cancer, 80(4), 1993, pp. 299-309
Authors:
BOAZIZ C
Citation: C. Boaziz, MALIGNANT-MELANOMA, Bulletin du cancer, 80, 1993, pp. 190000073-190000077
Risultati:
1-14
|